Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?

Ann Rheum Dis. 2003 Jun;62(6):591; author reply 591-2. doi: 10.1136/ard.62.6.591.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / blood
  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / genetics*
  • Drug Resistance / genetics
  • Humans
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Statistics, Nonparametric

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antirheumatic Agents
  • Methotrexate